@Article{Hunyady2018,
journal="Clinical and Experimental Hepatology",
issn="2392-1099",
volume="4",
number="2",
year="2018",
title="Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy",
author="Hunyady, Béla
and Abonyi, Margit
and Gerlei, Zsuzsanna
and Gervain, Judit
and Horváth, Gábor
and Jancsik, Viktor
and Lengyel, Gabriella
and Makkai, Erzsébet
and Pár, Alajos
and Péter, Zoltán
and Pusztay, Margit
and Ribiczey, Pál
and Rókusz, László
and Sarrazin, Christoph
and Schneider, Ferenc
and Susser, Simone
and Szalay, Ferenc
and Tornai, István
and Tusnádi, Anna
and Újhelyi, Eszter
and Werling, Klára
and Makara, Mihály",
pages="83--90",
doi="10.5114/ceh.2018.75957",
url="http://dx.doi.org/10.5114/ceh.2018.75957"
}